

Composition: The composition section of the supplied instruction states: 1 tablet contains D,L-hopantenic acid 300 mg; excipients: microcrystalline cellulose 20.97 mg, magnesium stearate 1.53 mg. The description and dosing sections of the same document refer to hard gelatin capsules.
Form: Capsules
Indications: • Cognitive impairment in organic brain lesions, including sequelae of neuroinfections and traumatic brain injury, and neurotic disorders. • Cerebrovascular insufficiency caused by atherosclerotic changes in cerebral vessels. • Extrapyramidal hyperkinesias, including myoclonus epilepsy, Huntington’s chorea, hepatolenticular degeneration and Parkinson’s disease; treatment of extrapyramidal syndrome caused by antipsychotics. • Epilepsy, with anticonvulsants. • Psychoemotional overload, reduced mental and physical performance, to improve concentration and memory. • Neurogenic urinary disorders: pollakiuria, imperative urges, urge incontinence, enuresis. • Schizophrenia, as part of combination treatment.
Contraindications: Hypersensitivity, children under 18 years, acute severe kidney diseases, pregnancy and breastfeeding.
Dosage: Orally, 15–20 minutes after meals, 1–3 capsules (0.3–0.9 g) 2–3 times daily, preferably in the morning and daytime. Maximum daily dose: 8 capsules (2.4 g). Treatment course: 1–4 months, sometimes 6–12 months. A repeat course is possible after 3–6 months.
Side effects: Rare: allergy (rhinitis, skin rash), insomnia, headache, nausea. Very rare: drowsiness, dizziness, tinnitus, abdominal pain.
Interactions: Enhances the effect of anticonvulsants and local anesthetics, prolongs the action of barbiturates. Enhances the effect of glycine and etidronic acid. Reduces side effects of neuroleptics and phenobarbital.
Warnings: Not recommended to combine with other nootropics during long-term use. Prescription only.
Age restrictions: From 18 years
Pregnancy: Contraindicated during pregnancy and breastfeeding.
Country of origin: Russia
Manufacturer: PIK-PHARMA
Storage conditions: Store in a dry, dark place at a temperature not exceeding 25 °C. Keep out of reach of children.
Russian Medical Journal, 2015
Authors: PhD V.N. Shishkova, L.I. Zotova
ReadPharmateca, 2010
Authors: S.N. Duma
ReadJournal of Neurology and Psychiatry, 2016
Authors: A.B. Gecht, L.S. Kanaeva, A.S. Avedisova, M.P. Marachev, K.V. Zakharova, G.K. Dashkina, E.V. Kulikova
ReadReview of Psychiatry and Medical Psychology, 2017
Authors: N.G. Neznanov, V.A. Mikhailov, L.V. Lukina, N.Y. Safonova
ReadMental Disorders in General Medicine, 2009
Authors: V.E. Medvedev, K.A. Albantova
ReadPsychiatry and Psychopharmacotherapy, 2009
Authors: L.S. Kanaeva, T.I. Vazagaeva, V.V. Yastrebova
Read